Authors


Siegfried Priglinger, MD

Latest:

Q&A: Siegfried Priglinger, MD, on the long-term outcomes of gene therapy in preschool kids

Siegfried Priglinger, MD discussed research he presented focused on pediatric patients with inherited retinal diseases with an emphasis on studies into the RPE65 gene.


Nita Valikodath, MD, MS

Latest:

Envision Summit 2025: Surgical challenges of a pediatric retinal detachment secondary to trauma

At the Envision Summit 2025 in San Juan, Puerto Rico, Nita Valikodath, MD, MS, gave insight into a challenging case of a 14-year-old boy who had trauma-related retinal detachment in his right eye, where a further macula-on retinal detachment with retinal dialysis was found in the left.


Marc Bosem, MD

Latest:

Seeking a solution to the anesthesia provider shortage

Office-based surgery could prove to be a viable option for physicians.


Nadia K. Waheed, MD, MPH

Latest:

Future of Intravitreal Injection

Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.


Viha Vig

Latest:

ARVO 2025: Association between ocular and systemic mitochondrial diseases and dementia

At ARVO 2025, in Salt Lake City, Utah, Viha Vig, talked about her poster presentation investigating the relationship between ocular and systemic mitochondrial diseases and dementia


AnnMarie Hipsley, DPT, PhD

Latest:

ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents AI-driven digital twin for simulation of aging eye

The Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize presbyopia treatment across the lifecycle.


Ehsan Rahimy, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Mary Walker

Latest:

Optical dispensary conversions

Practices can turn a moment of crisis into a win-win for all.


Laurent Bataille, PhD

Latest:

The relationship between myopia and conjunctival-scleral geometry

Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.



Claudio Trindade MD, PhD

Latest:

New IOLs for keratoconus and other aberrated corneas

Anterior segment surgeon expands on the use of the XtraFocus pinhole implant.


Michel Michaelides, MD, FRCOphth

Latest:

Focus on molecular mechanisms underlying cataract development

Several hundred genes are associated with congenital forms.


Osama Al Deyabat, MD

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.


Sunita Radhakrishnan, MD

Latest:

Electrical neurostimulation for glaucoma with Sunita Radhakrishnan, MD

Sunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.


Anika Tanwani, BS

Latest:

Froin syndrome: Eyes are the window to the spine

Papilledema with back pain suggests spine lesion.


Monique M. Barbour, MD

Latest:

50 years of ophthalmology: What changed the game (Part 1)

In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.


Emily Kaiser Maharjan

Latest:

FDA approves Lenz Therapeutics’ VIZZ for the treatment of presbyopia

Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.



John A. Vukich, MD

Latest:

Toric stability: A minor change with a major impact for patients

Lens offering surgeons a reassuring amount of resistance to movement in the eye


Rachel Babij, MD, PhD

Latest:

Advancing Fuchs dystrophy care: Longterm success of descemet stripping only

Deepinder Dhaliwal, MD, LAc, explores advancements in managing Fuchs endothelial corneal dystrophy, highlighting Descemet stripping only (DSO). Long-term outcomes show promising results, supporting DSO as a viable alternative to traditional donor-tissue-based keratoplasty procedures.


Stelian Curca, MD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.


Gloria B. Chiu, OD, FAAO, FSLS

Latest:

More to keratoconus than meets the cornea: Be sure to flip the lids

Equally important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.


Selina R. McGee, OD, FAAO

Latest:

Impressions and Key Takeaways From Patient Case #2

Selina McGee, OD, FAAO, emphasizes the significance of a multifactorial treatment approach for dry eye, especially in patients concurrently using other eye drops or contact lenses, and advocates for ocular sparing therapies when needed.


Achim Langenbucher, PhD

Latest:

Evolution of optical coherence tomography of the human eye

Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.


Roger K. Henry, MBS, BS

Latest:

Editorial: Ophthalmology during COVID-19

A residency applicant shares his perspective on the pandemic’s impact.


Sherrol Reynolds, OD, FAAO

Latest:

Envision Summit 2025: Patient-centered care and newest treatment strategies in neovascular AMD and DME

At the Envision Summit 2025 in San Juan, Puerto Rico, Sherrol Reynolds, OD, FAAO, participated in a discussion on patient-centered care and the newest treatment strategies in neovascular AMD and DME.


Karolinne Maia Rocha, MD, PhD

Latest:

Customizing patients’ vision with violet light filtration

The latest IOLs offer an improvement in stray light performance and enhanced contrast.


Renato Ambrósio Jr, MD, PhD

Latest:

Artificial intelligence for the early detection of ectatic corneal diseases

Advances enhance clinical decision-making in screening cases at risk of iatrogenic ectasia.


Diana Do, MD

Latest:

ARVO 2025: Update on the LIGHTSITE III study in AMD

At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.


Yesha Raval

Latest:

Expanding access, enhancing research: The evolving landscape of ophthalmic clinical trials

Changing demographics and increasing trial complexity present challenges and opportunities.

© 2025 MJH Life Sciences

All rights reserved.